-
COST-EFFECTIVENESS ANALYSIS OF RIBOCICLIB PLUS ENDOCRINE THERAPY (ET) VERSUS ABEMACICLIB PLUS ET IN THE ADJUVANT TREATMENT OF NODE POSITIVE PRE AND POSTMENOPAUSAL WOMEN WITH HR+/HER2- EARLY BREAST CANCER (EBC): A CANADIAN PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
STUDY ON THE ACCESSIBILITY OF ORPHAN DRUGS IN CHINA'S URBAN CUSTOMIZED COMMERCIAL MEDICAL INSURANCE
Mar 18, 2026, 21:38 PM -
TREND IN OPEN AND LAPAROSCOPIC APPENDECTOMY RATES ACROSS CENTRAL AND EASTERN EUROPEAN COUNTRIES (2015-2024)
Mar 18, 2026, 21:38 PM -
COST-UTILITY OF TENOFOVIR DISOPROXIL FUMARATE VERSUS ENTECAVIR FOR CHRONIC HEPATITIS B IN INDIA: A MARKOV STATE-TRANSITION MODEL
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC BURDEN ASSOCIATED WITH PROLONGED AIR LEAKS AMONG PATIENTS UNDERGOING WEDGE/SEGMENTECTOMY: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
CHARACTERIZING AGE-RELATED PATTERNS IN HEALTHCARE COSTS AND UTILIZATION AMONG PEOPLE LIVING WITH ANGELMAN SYNDROME IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
COST PER CLINICAL WEIGHT-LOSS GOAL ACHIEVEMENT WITH SEMAGLUTIDE 2.4 MG VERSUS LIRAGLUTIDE 3 MG FROM A COLOMBIAN INSURER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
INDIRECT TREATMENT COMPARISON OF TEPROTUMUMAB VS RITUXIMAB OR TOCILIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH LONGITUDINAL TRAJECTORIES OF HYDROXYUREA ADHERENCE AMONG INDIVIDUALS WITH SICKLE CELL DISEASE: A GROUP-BASED TRAJECTORY MODELING STUDY
Mar 18, 2026, 21:38 PM -
ESTIMATING PRICE ELASTICITIES OF ALCOHOL DEMAND IN CHINA (2010-2024)
Mar 18, 2026, 21:38 PM -
USING EXTENDED COX MODELS WITH TIME-VARYING COVARIATES TO EXAMINE EFFECT OF VARIABLE OPIOID EXPOSURE IN CANCER RECURRENCE IN DISEASE-FREE BREAST CANCER SURVIVORS
Mar 18, 2026, 21:38 PM -
REAL-WORLD ECONOMIC BURDEN AND HEALTHCARE UTILIZATION DRIVERS IN AUTISM SPECTRUM DISORDER: A LONGITUDINAL ANALYSIS OF EHR AND CLAIMS DATA (2017-2025)
Mar 18, 2026, 21:38 PM -
A MODELING STUDY INVESTIGATING THE POTENTIAL OF MULTI-CANCER EARLY DETECTION SCREENING IN REDUCING CANCER INCIDENCE AND MORTALITY IN HIGH-RISK GROUPS
Mar 18, 2026, 21:38 PM -
A MULTI-INDICATION HEALTH TECHNOLOGY ASSESSMENT FRAMEWORK FOR ONCOLOGICAL DRUGS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF PHARMACOLOGICAL TREATMENTS FOR STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CHINESE POPULATION: A BAYESIAN NETWORK META ANALYSIS
Mar 18, 2026, 21:38 PM -
PREDICTORS OF GLP-1 RECEPTOR AGONIST USE AMONG U.S. ADULTS WITH COMORBID DEPRESSION AND TYPE 2 DIABETES MELLITUS
Mar 18, 2026, 21:38 PM -
THE IMPACT OF SIMPLIFIED DOSING TERMINOLOGY ON TREATMENT EXPOSURE AND BUSGET IMPACT ESTIMATES
Mar 18, 2026, 21:38 PM -
UNIT-CONSISTENT TRANSLATION OF TREATMENT EFFECTS INTO NUMBER NEEDED TO TREAT AND COST PER EVENT AVOIDED IN HEALTH ECONOMIC EVALUATIONS
Mar 18, 2026, 21:38 PM -
THE IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS ON THE ECONOMIC BURDEN OF BLADDER CANCER IN CANADA
Mar 18, 2026, 21:38 PM -
DATA-DRIVEN BASELINE MATCHING: ENHANCING INDIRECT COMPARISONS WITH A MACHINE LEARNING-INFORMED FRAMEWORK FOR SELECTING HOMOGENEOUS TRIAL SETS
Mar 18, 2026, 21:38 PM
